Home/Filings/4/0000899243-19-020701
4//SEC Filing

Kwon Paul 4

Accession 0000899243-19-020701

CIK 0001566044other

Filed

Jul 30, 8:00 PM ET

Accepted

Jul 31, 6:33 PM ET

Size

5.9 KB

Accession

0000899243-19-020701

Insider Transaction Report

Form 4
Period: 2019-07-29
Kwon Paul
Chief Scientific Officer
Transactions
  • Award

    Restricted Stock Units

    2019-07-29+80,300396,812 total
    Common Stock (80,300 underlying)
Footnotes (3)
  • [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive a share of the Issuer's common stock.
  • [F2]The RSUs shall vest in two (2) equal annual installments beginning July 29, 2020, provided Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.
  • [F3]Not Applicable

Issuer

Menlo Therapeutics Inc.

CIK 0001566044

Entity typeother

Related Parties

1
  • filerCIK 0001727717

Filing Metadata

Form type
4
Filed
Jul 30, 8:00 PM ET
Accepted
Jul 31, 6:33 PM ET
Size
5.9 KB